These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3906168)

  • 21. [Pharmacokinetics and urinary excretion of aspoxicillin after consecutive administration at a dose of 4 grams].
    Arakawa S; Matsui T; Maeda H; Sako M; Sugino M; Ka S; Nakasuji T; Fujii A; Kamidono S; Maezawa I
    Jpn J Antibiot; 1988 Jan; 41(1):37-47. PubMed ID: 3367513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental and clinical studies of aspoxicillin in the pediatric field].
    Motohiro T; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Tominaga K
    Jpn J Antibiot; 1985 Jul; 38(7):1951-71. PubMed ID: 4068228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Piperacillin-amikacin combinations: killing curves].
    Chanal M; Sirot J; Chanal C; Cluzel M; Sirot D; Joly B
    Pathol Biol (Paris); 1990 Sep; 38(7):682-9. PubMed ID: 2122398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.
    Hayashi T; Watanabe Y; Kumano K; Kitayama R; Yasuda T; Saikawa I; Totsuka K; Kumada T; Shimizu K
    J Antibiot (Tokyo); 1986 May; 39(5):699-712. PubMed ID: 3733519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A clinical evaluation of aspoxicillin in children].
    Sato T; Ueda K; Kuroiwa T
    Jpn J Antibiot; 1985 Jul; 38(7):1944-50. PubMed ID: 4068227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology].
    Yasuda J; Yamamoto T; Honjo H; Okada H; Kanao M; Yamamoto H
    Jpn J Antibiot; 1982 Oct; 35(10):2337-42. PubMed ID: 6223151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative clinical study of aspoxicillin and sulbenicillin in postoperative wound infections].
    Yura J; Shinagawa N; Ishikawa S; Sakabe T; Iwai S; Sato T; Sakai K; Fujimoto M; Ueda T; Orita K
    Jpn J Antibiot; 1985 Sep; 38(9):2417-43. PubMed ID: 3852899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics and clinical effects of aspoxicillin in pediatric patients].
    Fujii R; Meguro H; Kim B; Yonezawa H; Kawaoi T; Tajima T; Mashiko J; Nakazawa S; Niino K; Sato H
    Jpn J Antibiot; 1987 Sep; 40(9):1651-67. PubMed ID: 3694789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory and clinical studies on aspoxicillin in the field of pediatrics].
    Ueda S; Hayakawa F; Nakashima T; Miyachi Y; Hakamada T; Kuno K
    Jpn J Antibiot; 1985 Jul; 38(7):1853-67. PubMed ID: 3851859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on aspoxicillin for its transfer to the skin].
    Kurokawa M; Suzuki S; Matsuda K; Nakamura A; Matsushita Y; Kitahara AK; Aoki H; Ota M; Takaba K; Naito M
    Jpn J Antibiot; 1994 Feb; 47(2):215-8. PubMed ID: 8151914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin).
    Thamlikitkul V; Tiengrim S; Chalermsri C; Sae-Jong R; Suddhichupaiboon S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S196-202. PubMed ID: 21721447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic studies of piperacillin after 4 g or 8 g intravenous injection in human healthy volunteers].
    Nakagawa K; Yasuda T; Nakajima Y; Watanabe Y; Noguchi M; Suzuki T
    Jpn J Antibiot; 1982 Dec; 35(12):2797-804. PubMed ID: 6222208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic study on aspoxicillin transfer into pulmonary and tracheal tissues].
    Nakai K; Tokushima T; Hirota Y; Nagamatsu M; Takeda K; Mizobe M; Takai C
    Jpn J Antibiot; 1993 May; 46(5):367-73. PubMed ID: 8326676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical studies on aspoxicillin in the field of pediatrics].
    Hosoda T; Masuda M; Ichioka T; Miyao M
    Jpn J Antibiot; 1985 Jul; 38(7):1905-10. PubMed ID: 3851862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.